Down regulation of c-Myc and induction of an angiogenesis inhibitor, thrombospondin-1, by 5-FU in human colon cancer KM12C cells

Cancer Lett. 2008 Oct 18;270(1):156-63. doi: 10.1016/j.canlet.2008.04.045. Epub 2008 Jun 25.

Abstract

5-FU is commonly used for treatment of various solid tumors including colon carcinoma. We have previously demonstrated that Egr-1 induced by 5-FU enhanced TSP-1 expression in human colon cancer KM12C cells. In this study, a Genechip analysis of KM12C cells treated with 5-FU revealed down-regulation of 924 genes and up-regulation of 460 genes. The decreased expression of c-Myc mRNA and phosphorylated c-Myc were detected and confirmed by RT-PCR and immunoblotting. Since 5-FU induced the expression of TSP-1, we examined the effect of c-Myc on the TSP-1 promoter. Deletion of the TSP-1 promoter region in which binding sites for c-Myc reside had no effect on the TSP-1 promoter activity induced by 5-FU. Meanwhile, 5-FU dose-dependently decreased the expression of miR-17-92 cluster. These findings suggest that 5-FU decreased the expression of c-Myc and consequently miR-17-92 cluster and increased the expression of TSP-1 mRNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiogenesis Inhibitors / genetics*
  • Antimetabolites, Antineoplastic / pharmacology*
  • Cell Line, Tumor
  • Colonic Neoplasms / drug therapy*
  • Colonic Neoplasms / genetics
  • Colonic Neoplasms / pathology
  • Down-Regulation
  • Fluorouracil / pharmacology*
  • Gene Expression Regulation, Neoplastic / drug effects*
  • Genes, myc*
  • Humans
  • MicroRNAs / genetics
  • Multigene Family
  • Oligonucleotide Array Sequence Analysis
  • Promoter Regions, Genetic*
  • Thrombospondin 1 / genetics*

Substances

  • Angiogenesis Inhibitors
  • Antimetabolites, Antineoplastic
  • MIRN17 microRNA, human
  • MicroRNAs
  • Thrombospondin 1
  • Fluorouracil